STAN036i-49-2
Donor lungs were donated at time of death and are available through the Pulmonary Hypertension Breakthrough Initiative (PHBI). An additional clone from this iPS cell line (STAN035i-49-1) is available from WiCell.| Cell Line Alias | IPSVNOC2 |
| Cell Type | Human iPS |
| Disease | None reported |
| Diagnosis Information | Diagnosis of Associated Pulmonary Arterial Hypertension with ventricular septal defect and Eisenmenger's Syndrome was physician reported. |
| Sex | Male |
| Age at Collection | 25 Years |
| Ethnicity | Caucasian |
| Ethnicity Information | Self-reported |
| Genetically Related Cell Lines | |
| Reprogramming Method | Non-integrating (Sendai: Oct4, Klf4, Sox2, cMyc) |
| Tissue Origin | Skin |
| Provider | Stanford University - Dr. Marlene Rabinovitch |
| dbGaP Data | |
| hPSCReg ID | |
| NIH Approval | |
| Pub Med Abstract | |
| Collection(s) | NHLBI Next Gen - Pulmonary Artery Hypertension (Dr. Marlene Rabinovitch, Stanford University) |
Current Lot Information
| Lot Number | Culture Platform | Lot Description | Passage Number | Banked By | Protocol | Product Information & Testing |
|---|---|---|---|---|---|---|
| DB30900 | E8/Matrigel | 10 | Provider | WiCell Feeder Independent Pluripotent Stem Cell Protocol |
